STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia (STO:BIOG-B) has signed a non-exclusive agreement with Pharma Base SA for the rights to sell BioGaia’s ProTectis Baby Drops in India. Pharma Base will cooperate with a local distributor for the marketing and sales of the drops, which will be sold under BioGaia’s own brand. The registration of the product will start 2014 and the launch is planned to the beginning of 2015.
Help employers find you! Check out all the jobs and post your resume.
